ELIZABETH SPOLJORIC: Open Payments
NPI 1457057341 · LA PORTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 18 payments from 9 companies in 2025. Trend: 2023 $295 · 2024 $338 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 5 | $102 |
| Biogen, Inc. | 2 | $47 |
| ABBVIE INC. | 3 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $37 |
| Astellas Pharma US Inc | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Organon LLC | 1 | $9 |
Products named: SLYND, ZURZUVAE, VRAYLAR, JOURNAVX, Veozah, Mirena, The Cologuard Plus Collection Kit, CAPLYTA.
Industry payments across IN — which companies pay providers there.
